Tesamorelin Dosage Guide
90/100 confidenceComplete guide to Tesamorelin dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Dosage Overview
Dose Range
2 mg
Route
subq
Frequency
1x daily
Reconstitution
Vial Size
2 mg
BAC Water
2 ml
Concentration
1,000 mcg/ml
Detailed Dosage Information
FDA-approved dose: 2mg administered subcutaneously once daily. Research protocols may use various dosing schedules.
Administration Method
Subcutaneous injection into the abdomen. Rotate injection sites. Best administered at the same time daily, preferably in the evening.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Quick Calculator
Concentration: 1,000 mcg/ml
Volume to inject: 2.00 ml
Syringe units (U-100): 200.0 units
Pre-filled with Tesamorelin defaults. Adjust values as needed.
Research Backing
Phase 3 trials \+ full FDA prescribing information (Egrifta®); visceral fat reduction studies.
Side Effects to Monitor
Common side effects include injection site reactions (erythema, pruritus), joint pain, peripheral edema, and muscle pain. May cause elevated blood glucose.
Safety Considerations & Risks
Contraindicated in patients with active malignancy, hypersensitivity to GHRH, or during pregnancy. May affect glucose metabolism. Requires monitoring of IGF-1 levels.